nup211 Antibody

What is Nup211 and why is it important in cellular research?

Nup211 is a basket nucleoporin found in fission yeast that is essential for cell viability. It plays crucial roles in multiple cellular processes, including mRNA export, gene expression regulation, and cell cycle progression. Research has shown that Nup211 preferentially associates with heterochromatin and its depletion leads to severe defects in cell cycle progression, particularly affecting septation and cytokinesis . Understanding Nup211 function is important for broader insights into nuclear pore complex (NPC) biology and nucleocytoplasmic transport. When working with Nup211 antibodies, researchers should consider the protein's localization at the nuclear periphery and its essential nature for experimental design and interpretation .

What types of Nup211 antibodies are available for research applications?

Based on current research literature, both mouse and rabbit anti-Nup211 antibodies are available for research applications . These antibodies have been successfully used in various experimental techniques, including Western blotting and immunofluorescence microscopy. When selecting a Nup211 antibody, researchers should consider the specific application (Western blot, immunoprecipitation, immunofluorescence, etc.) and the species compatibility with their experimental system. For fission yeast studies, the antibodies mentioned in the literature have been validated and shown to specifically detect Nup211 protein in various assays .

How can I validate the specificity of a Nup211 antibody for my experiments?

To validate Nup211 antibody specificity, several approaches can be employed:

• Use a conditional mutant strain like the nup211-so strain where Nup211 expression can be regulated (e.g., by thiamine), and confirm reduced antibody signal when the protein is depleted .

• Perform Western blotting with wild-type and Nup211-depleted samples to confirm the absence or significant reduction of the signal at the expected molecular weight in depleted samples .

• For truncation studies, use CRISPR-generated Nup211 truncation mutants (such as nup211 or 1-863 nup211) to confirm the antibody recognizes the relevant domains .

• Include appropriate negative controls in immunofluorescence microscopy to distinguish between specific nuclear envelope staining and background signals .

The validation process is critical as it ensures that experimental observations truly reflect Nup211 biology rather than non-specific antibody interactions.

What are the recommended protocols for using Nup211 antibodies in Western blotting?

When using Nup211 antibodies for Western blotting, researchers should consider the following methodological approaches:

• Sample preparation: Harvest cells at mid-log phase (OD₆₀₀ ≈ 0.3) to ensure consistent protein expression levels .

• Protein extraction: Use appropriate lysis buffers that maintain nuclear protein integrity, as Nup211 is a nuclear pore complex protein.

• Gel electrophoresis: Use an appropriate percentage gel to resolve the full-length Nup211 protein (~200 kDa) or specific domains being studied.

• Primary antibody incubation: Dilute mouse or rabbit anti-Nup211 antibodies according to manufacturer recommendations (typically 1:1000 to 1:5000).

• Controls: Include positive controls (wild-type cells) and negative controls (Nup211-depleted cells) to assess antibody specificity .

• Detection: For analyzing protein domains or truncation mutants, ensure your detection method has sufficient sensitivity to detect both full-length and truncated proteins .

When analyzing results, researchers should be aware that Nup211 protein levels may vary depending on cell cycle stage and growth conditions.

How can Nup211 antibodies be optimized for immunofluorescence microscopy in fission yeast?

Optimizing Nup211 antibodies for immunofluorescence microscopy in fission yeast requires careful consideration of several factors:

• Fixation method: Since Nup211 localizes to the nuclear periphery, use a fixation protocol that preserves nuclear membrane structure. Paraformaldehyde fixation (typically 3-4%) is often suitable for nuclear pore proteins.

• Cell wall digestion: Fission yeast has a rigid cell wall that can impede antibody penetration. Use enzymes like zymolyase or lysing enzymes to create spheroplasts while maintaining cellular integrity.

• Antibody penetration: After fixation and cell wall digestion, permeabilize cells with a detergent like Triton X-100 (0.1-0.5%) to allow antibody access to nuclear structures.

• Blocking: Use BSA or normal serum from the secondary antibody host species to reduce background.

• Co-staining: Consider co-staining with DAPI for nuclei and aniline blue for septa, especially when examining the effects of Nup211 on cytokinesis .

• Controls: Include cells with depleted Nup211 (e.g., nup211-so grown with thiamine) to confirm specificity of the nuclear envelope staining pattern .

• Imaging: Use confocal microscopy to clearly visualize the nuclear envelope localization of Nup211.

The nuclear rim staining pattern should be evident in wild-type cells but significantly reduced in Nup211-depleted cells.

What approaches can be used to study domain-specific functions of Nup211 using antibodies?

To study domain-specific functions of Nup211 using antibodies, researchers can employ several sophisticated approaches:

• Domain-specific antibodies: Generate or obtain antibodies that recognize specific domains of Nup211 (N-terminal, central, or C-terminal regions).

• Epitope mapping: Use truncated Nup211 constructs (such as Nup211 1-655, 1-863, or 1-1033) to map which domains of Nup211 are recognized by different antibodies .

• Domain deletion analysis: Compare antibody signals in wild-type cells versus cells expressing specific Nup211 domain truncations (like the 1-655 nup211 strain) to assess antibody specificity and domain localization .

• Co-immunoprecipitation: Use Nup211 antibodies to immunoprecipitate protein complexes, then analyze which interaction partners associate with specific domains.

• ChIP analysis: If studying transcriptional regulation functions, perform chromatin immunoprecipitation with Nup211 antibodies in various domain truncation backgrounds to identify domain-specific chromatin interactions.

The research data indicates that the N-terminal 655 amino acids of Nup211 are sufficient for cell viability and can partially rescue gene expression defects in Nup211-depleted cells, making this domain particularly important for functional studies .

How can Nup211 antibodies be used to investigate the relationship between Nup211 and gene expression regulation?

Using Nup211 antibodies to investigate the role of Nup211 in gene expression regulation can be approached through several methodologies:

• Chromatin Immunoprecipitation (ChIP): Use Nup211 antibodies to perform ChIP followed by sequencing (ChIP-seq) to identify genomic regions where Nup211 associates with chromatin. Focus on genes identified in RNA-Seq studies as being regulated by Nup211, such as atf1, mbx1, pom1, knh1, pxl1, and bgs1 .

• Immunoprecipitation followed by mass spectrometry (IP-MS): Immunoprecipitate Nup211 protein complexes to identify transcription factors or chromatin modifiers that interact with Nup211.

• Proximity ligation assay (PLA): Investigate the physical proximity between Nup211 and transcription factors related to cytokinesis genes (like Ace2) using antibodies against both proteins.

• Combined approaches with gene expression analysis: Perform Nup211 ChIP in parallel with RNA-Seq or RT-qPCR in wild-type versus Nup211-depleted cells to correlate Nup211 binding with changes in gene expression .

• Domain-specific regulation analysis: Use antibodies against different Nup211 domains in combination with truncation mutants to determine which regions are responsible for regulating specific genes. Research has shown that the N-terminal 655 amino acids can rescue the expression of some genes (atf1, mbx1, pom1, knh1, pxl1, and agn1) but not others (bgs1, agn2, and adg1) .

These approaches can help elucidate the mechanisms by which Nup211 influences the expression of genes involved in cytokinesis and cell cycle progression.

What are the best practices for troubleshooting non-specific binding when using Nup211 antibodies?

When encountering non-specific binding with Nup211 antibodies, consider these advanced troubleshooting approaches:

• Antibody validation in knockout/knockdown systems:

  • Use the nup211-so strain with and without thiamine to create positive and negative controls

  • Compare antibody signal between these conditions to distinguish specific from non-specific binding

• Optimization of blocking conditions:

  • Test different blocking agents (BSA, milk, normal serum)

  • Increase blocking time or concentration to reduce background

  • Consider adding 0.1-0.5% Tween-20 or Triton X-100 to washing buffers

• Peptide competition assays:

  • Pre-incubate the antibody with excess purified Nup211 peptide

  • If the specific signal disappears but background remains, this identifies non-specific binding

• Cross-reactivity analysis:

  • Test antibody recognition of different Nup211 truncations (1-655, 1-863, 1-1033)

  • Identify whether non-specific binding occurs with specific protein domains

• Alternative antibody strategies:

  • Test both mouse and rabbit anti-Nup211 antibodies to determine if one shows less non-specific binding

  • Consider generating epitope-tagged versions of Nup211 and using highly specific tag antibodies

• Species-specific considerations:

  • When working with different yeast species or comparing to mammalian systems, be aware that sequence conservation may affect antibody specificity

Documentation of all optimization steps is crucial for reproducibility and method development.

How should experiments be designed to study the interaction between Nup211 and the cell cycle using antibodies?

To study Nup211's role in cell cycle regulation using antibodies, consider the following experimental design approach:

• Synchronization strategies:

  • Synchronize fission yeast cells using methods like nitrogen starvation or temperature-sensitive cell cycle mutants

  • Collect samples at defined cell cycle stages (G1, S, G2, M)

  • Analyze Nup211 levels, modifications, and localization using antibodies at each stage

• Co-localization studies:

  • Perform dual immunofluorescence with Nup211 antibodies and markers for cell cycle progression

  • Use DAPI staining to track nuclear division and aniline blue to visualize septa formation and cytokinesis

  • Quantify changes in Nup211 localization pattern throughout the cell cycle

• Protein-protein interactions during cell cycle:

  • Conduct co-immunoprecipitation with Nup211 antibodies at different cell cycle stages

  • Identify cycle-specific interaction partners

• Conditional depletion time course:

  • Use the nup211-so strain with thiamine addition to deplete Nup211 at specific cell cycle stages

  • Monitor immediate effects on cell morphology, septation, and cytokinesis

  • Correlate protein depletion (via Western blot) with phenotypic changes

• Quantitative analysis of septation defects:

  • Score multiple septation phenotypes (misplaced, thicker, or multiple septa) in Nup211-depleted cells

  • Correlate specific defects with changes in expression of cytokinesis genes like agn1, agn2, and adg1

This comprehensive approach allows researchers to determine whether Nup211's role in the cell cycle is direct or indirect, and to identify specific stages where it has the most significant impact.

What controls should be included when using Nup211 antibodies for chromatin immunoprecipitation (ChIP) experiments?

When performing ChIP experiments with Nup211 antibodies, the following controls are essential for robust and interpretable results:

• Input controls:

  • Reserve a portion of chromatin before immunoprecipitation (typically 5-10%)

  • Use this to normalize ChIP signals and account for differences in starting material

• Negative controls:

  • No-antibody control to assess non-specific binding to beads/matrix

  • IgG control (same species as the Nup211 antibody) to establish background signal

  • Nup211-depleted samples (e.g., nup211-so with thiamine) to validate specificity

• Positive controls:

  • ChIP for regions known to be bound by Nup211, if available

  • ChIP for genomic regions near genes known to be regulated by Nup211 (e.g., atf1, mbx1, pom1)

• Domain specificity controls:

  • If studying domain-specific functions, include ChIP with truncated Nup211 strains (e.g., 1-655 nup211)

  • Compare binding profiles between full-length and truncated proteins

• Technical controls:

  • Sonication efficiency check to ensure appropriate chromatin fragmentation

  • PCR/primer efficiency controls for ChIP-qPCR

  • Spike-in controls for ChIP-seq normalization

• Biological replicates:

  • Minimum of three biological replicates to establish reproducibility

  • Consider replicate experiments under different growth conditions

These controls will help distinguish genuine Nup211-chromatin interactions from experimental artifacts and allow for accurate interpretation of the role of Nup211 in chromatin organization and gene regulation.

How can researchers quantitatively analyze changes in Nup211 protein levels during experimental interventions?

For quantitative analysis of Nup211 protein levels during experimental interventions, researchers should implement the following methodological approach:

• Western blot quantification:

  • Use standardized protein extraction protocols for nuclear proteins

  • Include loading controls appropriate for nuclear proteins (e.g., histone H3)

  • Ensure linear detection range by performing dilution series

  • Employ digital image analysis software to quantify band intensities

  • Normalize Nup211 signal to loading control

• Time-course experiments:

  • For inducible systems like nup211-so, collect samples at defined time points after thiamine addition

  • Correlate protein depletion with the emergence of phenotypic defects

• Domain-specific quantification:

  • When studying truncated versions of Nup211, ensure antibodies recognize the relevant domains

  • Use domain-specific antibodies or epitope tags if necessary

• Absolute quantification methods:

  • Consider SILAC (Stable Isotope Labeling with Amino acids in Cell culture) or other mass spectrometry-based approaches

  • Use recombinant Nup211 standards for absolute quantification

• Single-cell analysis:

  • Implement immunofluorescence with standardized acquisition parameters

  • Perform automated image analysis to quantify nuclear envelope signal intensity

  • Correlate with cell cycle stage or morphological phenotypes

• Statistical analysis:

  • Apply appropriate statistical tests based on experimental design

  • Report both biological and technical variability

  • Consider using ANOVA for multi-condition experiments

• Data presentation:

  • Present data as fold-change relative to control conditions

  • Include error bars representing standard deviation or standard error

  • Show representative images alongside quantification

This comprehensive approach enables reliable quantification of Nup211 protein levels and facilitates correlation with functional outcomes in various experimental contexts.

How can epitope mapping be performed to better characterize Nup211 antibodies?

Epitope mapping of Nup211 antibodies can be accomplished through several complementary approaches:

• Domain truncation analysis:

  • Generate a series of Nup211 truncation constructs (similar to those used in the functional studies: Nup211 1-655, 1-863, 1-1033, 1-412, 1034-1837)

  • Express these constructs in nup211-so cells grown with thiamine to eliminate background from endogenous protein

  • Perform Western blotting to determine which constructs are recognized by the antibody

• Peptide array analysis:

  • Synthesize overlapping peptides (typically 15-20 amino acids) spanning the Nup211 sequence

  • Arrange peptides on a membrane or microarray

  • Probe with Nup211 antibody to identify reactive peptides

  • Focus particularly on the N-terminal region (1-655) which has been shown to be functionally important

• Alanine scanning mutagenesis:

  • For identified epitope regions, create point mutations changing key residues to alanine

  • Test antibody binding to these mutants to identify critical binding residues

• Competitive ELISA:

  • Coat plates with recombinant Nup211 protein or domains

  • Pre-incubate antibody with candidate epitope peptides

  • Measure reduction in antibody binding to identify peptides that compete for antibody binding

• Cross-reactivity assessment:

  • Test antibody recognition of orthologous proteins from related species

  • Identify conserved vs. divergent epitopes

• Crystallography or cryo-EM studies:

  • For high-resolution epitope mapping, co-crystallize antibody Fab fragments with Nup211 domains

  • Alternatively, use cryo-EM to visualize antibody-Nup211 complexes

This detailed epitope information can guide antibody selection for specific applications and help interpret results when studying domain-specific functions of Nup211.

What are the considerations for using Nup211 antibodies in co-immunoprecipitation experiments to identify interaction partners?

When using Nup211 antibodies for co-immunoprecipitation (co-IP) to identify interaction partners, researchers should consider the following technical aspects:

• Cell lysis conditions:

  • Use gentle lysis buffers that preserve protein-protein interactions

  • Consider nuclear isolation before lysis to enrich for nuclear pore components

  • Test different detergent types and concentrations to optimize extraction while maintaining interactions

• Antibody selection and immobilization:

  • Choose antibodies that recognize native Nup211 epitopes not involved in protein interactions

  • Consider using the knowledge about functional domains (e.g., N-terminal 1-655 region) to select antibodies

  • Pre-clear lysates to reduce non-specific binding

  • Cross-link antibodies to beads to prevent co-elution with target proteins

• Validation controls:

  • Perform IP in wild-type and Nup211-depleted (nup211-so + thiamine) cells

  • Include IgG control to identify non-specific binding

  • Use domain truncation mutants to map domain-specific interactions

• Washing conditions:

  • Optimize salt and detergent concentrations to reduce background while maintaining specific interactions

  • Consider stringency gradients to identify high-confidence vs. weaker interactors

• Interaction detection methods:

  • Western blotting for known or suspected interaction partners

  • Mass spectrometry for unbiased identification of the complete interactome

  • Consider SILAC or TMT labeling for quantitative comparison between conditions

• Functional validation:

  • Confirm interactions by reciprocal co-IP

  • Investigate whether interactors change in different cell cycle stages

  • Correlate interactions with genes whose expression is affected by Nup211 depletion

• Data analysis:

  • Filter out common contaminants using CRAPome or similar databases

  • Perform gene ontology analysis to identify enriched functional categories

  • Look for enrichment of proteins involved in cytokinesis and cell cycle regulation, given Nup211's role in these processes

These considerations will help identify genuine Nup211 interaction partners and provide insights into the mechanisms by which Nup211 influences various cellular processes.

How can researchers resolve contradictory results when using different Nup211 antibodies in their experiments?

When faced with contradictory results from different Nup211 antibodies, researchers should implement the following systematic approach to resolve discrepancies:

• Antibody characterization comparison:

  • Compare epitope locations for each antibody (if known)

  • Determine if antibodies recognize different domains of Nup211

  • Assess whether recognized epitopes might be masked in certain protein complexes or conformations

• Validation using genetic tools:

  • Test all antibodies against the nup211-so strain grown with and without thiamine

  • Evaluate antibody performance with truncation mutants (e.g., 1-655 nup211)

  • Create an epitope-tagged version of Nup211 as a reference standard

• Technical parameter assessment:

  • Systematically compare fixation methods, blocking conditions, and incubation parameters

  • Test antibodies at multiple dilutions to establish optimal working concentrations

  • Evaluate different detection systems (chemiluminescence vs. fluorescence)

• Post-translational modification considerations:

  • Determine if discrepancies could result from antibodies differentially recognizing modified forms of Nup211

  • Investigate whether experimental conditions affect Nup211 modifications

• Antibody cross-reactivity analysis:

  • Perform immunoprecipitation followed by mass spectrometry to identify all proteins recognized by each antibody

  • Test antibodies against related nucleoporins to assess specificity

• Combined approaches:

  • Use multiple antibodies simultaneously in the same experiment when possible

  • Create a consensus result based on multiple antibodies

  • Weight results based on antibody validation quality

• Documentation and reporting:

  • Thoroughly document all observed discrepancies

  • Report all antibody-specific results transparently in publications

  • Specify exact antibody clone, lot number, and experimental conditions

• Alternative detection strategies:

  • Consider creating a GFP-tagged Nup211 to circumvent antibody variability issues

  • Use alternative techniques like proximity labeling that don't rely on antibody recognition

This structured approach will help resolve contradictions and establish which antibody provides the most reliable results for specific applications.

How might Nup211 antibodies be used in studying nuclear pore complex dynamics during stress conditions?

Nup211 antibodies can be valuable tools for investigating nuclear pore complex (NPC) dynamics during stress conditions through these methodological approaches:

• Stress-induced relocalization studies:

  • Expose cells to various stressors (oxidative stress, heat shock, nutrient deprivation)

  • Track Nup211 localization changes using immunofluorescence microscopy

  • Quantify changes in nuclear envelope distribution patterns

• Stress-responsive interactions:

  • Perform co-immunoprecipitation with Nup211 antibodies under normal and stress conditions

  • Identify stress-specific interaction partners

  • Correlate with transcriptional changes in stress-response genes

• Post-translational modification analysis:

  • Use Nup211 antibodies to immunoprecipitate the protein from stressed cells

  • Perform mass spectrometry to identify stress-induced modifications

  • Develop modification-specific antibodies if key sites are identified

• Chromatin association dynamics:

  • Use ChIP with Nup211 antibodies under stress conditions

  • Determine if Nup211 associates with different genomic regions during stress

  • Correlate with expression changes in stress-response genes

• Nuclear transport assays:

  • Assess whether stress affects Nup211's role in mRNA export

  • Use Nup211 antibodies to visualize co-localization with mRNA export factors under stress

  • Correlate with the expression changes observed in Nup211-regulated genes

• Integration with the cell cycle response:

  • Given Nup211's role in cell cycle regulation, examine how stress-induced cell cycle checkpoints affect Nup211 function

  • Use synchronized cultures to determine stage-specific responses

• Domain-specific stress responses:

  • Use domain-specific antibodies or truncation mutants to determine if specific regions of Nup211 are particularly important for stress responses

  • Compare with the known functional importance of the N-terminal region (1-655)

These approaches will provide insights into how Nup211 contributes to cellular adaptation during stress and may reveal novel regulatory mechanisms.

What are the considerations for developing super-resolution microscopy protocols using Nup211 antibodies?

Developing super-resolution microscopy protocols with Nup211 antibodies requires careful attention to several technical considerations:

• Sample preparation optimization:

  • Optimize fixation to preserve nuclear pore structure while allowing antibody accessibility

  • Test different fixatives (formaldehyde, glutaraldehyde, methanol) and concentrations

  • Consider embedding samples in specialized resins for ultra-thin sectioning

• Antibody selection criteria:

  • Choose high-affinity, highly specific antibodies to maximize signal-to-noise ratio

  • Validate antibody specificity using nup211-so strains

  • Consider using directly labeled primary antibodies to reduce localization error

• Fluorophore selection:

  • Choose photostable fluorophores with appropriate spectral properties

  • For STORM/PALM, select fluorophores with optimal blinking characteristics

  • For STED, select fluorophores resistant to high-intensity depletion lasers

• Resolution calibration:

  • Use nuclear pore diameter (~100 nm) as an internal calibration reference

  • Measure the distance between Nup211 and other known nucleoporins to validate resolution

• Multi-color imaging strategies:

  • Develop protocols for co-localization with other nuclear pore proteins

  • Consider spectral unmixing for closely overlapping fluorophores

  • Use sequential imaging to reduce chromatic aberration effects

• Drift correction and image processing:

  • Implement fiducial markers for long acquisition protocols

  • Use computational drift correction algorithms

  • Apply appropriate deconvolution methods

• Quantitative analysis:

  • Develop custom analysis pipelines to quantify Nup211 distribution

  • Measure changes in nuclear pore density and arrangement in different conditions

  • Correlate with cell cycle stages or morphological phenotypes

• Correlative microscopy:

  • Consider combining super-resolution fluorescence with electron microscopy

  • Use Nup211 antibodies conjugated to both fluorophores and electron-dense markers

• Live-cell alternatives:

  • If fixed-sample approaches prove limiting, consider GFP-tagged Nup211 constructs for live super-resolution techniques

These considerations will enable visualization of Nup211 distribution at the nuclear pore with unprecedented detail, potentially revealing new insights into its functional organization.

How can computational approaches enhance the analysis of data generated using Nup211 antibodies?

Computational approaches can significantly enhance the analysis of Nup211 antibody-derived data through several advanced methodologies:

• Image analysis automation:

  • Develop machine learning algorithms for automated identification of nuclear pores in immunofluorescence images

  • Implement deep learning for classification of Nup211 localization patterns in different experimental conditions

  • Create automated pipelines for quantification of nuclear rim intensity, distribution, and morphology

• Integrative multi-omics analysis:

  • Combine ChIP-seq data from Nup211 antibodies with RNA-seq data from Nup211 depletion experiments

  • Integrate with proteomics data from co-immunoprecipitation studies

  • Develop network models of Nup211-regulated genes and their functional relationships

• Structural biology integration:

  • Use antibody epitope mapping data to refine structural models of the nuclear pore basket

  • Implement molecular dynamics simulations to predict how Nup211 domains interact with other proteins

  • Model the functional implications of the essential N-terminal domain (residues 1-655)

• Temporal analysis:

  • Develop computational approaches for tracking Nup211 dynamics throughout the cell cycle

  • Create mathematical models of how Nup211 regulation influences cytokinesis timing

  • Implement signal processing techniques for time-series analysis of Nup211 behavior

• Phenotypic correlation analysis:

  • Develop image analysis pipelines to automatically quantify the septation defects observed in Nup211-depleted cells

  • Correlate specific phenotypes with gene expression changes

  • Create predictive models for cell morphology based on Nup211 status

• Cross-species comparative genomics:

  • Compare Nup211 function across different yeast species

  • Develop algorithms to identify conserved regulatory elements in Nup211-regulated genes

  • Predict antibody cross-reactivity based on sequence conservation

• Spatial organization analysis:

  • Implement point pattern analysis to characterize the spatial distribution of Nup211 at the nuclear envelope

  • Use neighborhood analysis to identify co-localization patterns with other nucleoporins

  • Develop 3D reconstruction algorithms for visualizing the entire nuclear pore basket

These computational approaches will extract maximum information from experimental data, leading to deeper insights into Nup211 function and more efficient experimental design for future studies.